Technology Briefs
- Therapeutic targets for preventing non-alcoholic fatty liver disease
- Uncleavable Mertk knock-in mouse for studying cardiovascular and neuroinflammatory disease
- Diabetes drug as a candidate for treatment of obesity and other metabolic diseases
- Treatment of obesity and diabetes through the inhibition of MAPKAPK2 and MAPKAPK3
- Nanoparticles for targeted delivery of anti-inflammatory agent